AbbVie Investors Sue In Chancery Over $55B Shire Merger

By John Kennedy · May 4, 2017, 8:28 PM EDT

AbbVie Inc.'s shareholders on Thursday hit the biopharmaceutical company's board of directors with a proposed class action in Delaware Chancery Court, claiming the directors hid their decision to back out of...

To view the full article, register now.